3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
34
INDUSTRY
6
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Gastrointestinal
1
CNS
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
35
Lymphoma
32
Lymphoma, Non-Hodgkin
25
Lymphoma, B-Cell
15
Lymphoma, Follicular
13
Recurrence
11
Lymphoma, Large B-Cell, Diffuse
11
Hodgkin Disease
11
Leukemia
10
Multiple Myeloma
9
Burkitt Lymphoma
8
Leukemia, Myeloid, Acute
5
Neoplasms
4
Lymphoma, T-Cell, Peripheral
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Hematologic Neoplasms
4
Neoplasms, Plasma Cell
3
Myelodysplastic Syndromes
3
Lymphoma, T-Cell
3
Lymphoma, Mantle-Cell
3
Prostatic Neoplasms
2
Obesity
2
Neoplasm, Residual
2
Mycosis Fungoides
2
Lymphoma, B-Cell, Marginal Zone
2
Intraocular Lymphoma
2
HIV Infections
2
Febrile Neutropenia
2
Colonic Neoplasms
2
Breast Neoplasms
2
Interventions
fasudil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Cognitive Dysfunction
×
Lymphoid
×
Clear all
NCT06362707
2026-05-04
FEAD
Helse Stavanger HF
Phase 2
Recruiting
200 enrolled